Normal immunoglobulin (Human) 20% (20 g/100 mL), subcutaneous injection
HIZENTRA is a preparation of human immunoglobulin for subcutaneous use, which means HIZENTRA is infused just under the first layer of skin. HIZENTRA is prepared from plasma donated in the United States and Europe.
HIZENTRA is used to treat people who need replacement of antibodies.
HIZENTRA is available only with a doctor’s prescription.
The data sheet contains information to ensure the safe and effective use of a medicine. This document is approved by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority. It is made available by CSL Behring for you if you are a:
|a.||qualified healthcare professional; or |
|b.||consumer, provided you have read the Consumer Medicine Information for the product; want further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Product Information. |
HIZENTRA Data Sheet (PDF, 0.129MB)
Hizentra® is a Registered trademark of CSL Behring AG
Last Updated: 21/06/2015